Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
20.54
+0.28 (1.38%)
Nov 22, 2024, 4:00 PM EST - Market closed
Bicycle Therapeutics Revenue
Bicycle Therapeutics had revenue of $2.68M in the quarter ending September 30, 2024, a decrease of -50.00%. This brings the company's revenue in the last twelve months to $36.90M, up 48.60% year-over-year. In the year 2023, Bicycle Therapeutics had annual revenue of $26.98M with 86.52% growth.
Revenue (ttm)
$36.90M
Revenue Growth
+48.60%
P/S Ratio
28.70
Revenue / Employee
$129,923
Employees
284
Market Cap
1.42B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Guardian Pharmacy Services | 1.17B |
Myriad Genetics | 823.60M |
Alphatec Holdings | 572.74M |
MiMedx Group | 342.80M |
Day One Biopharmaceuticals | 101.95M |
Ocular Therapeutix | 61.44M |
Intellia Therapeutics | 43.09M |
Syndax Pharmaceuticals | 16.00M |
BCYC News
- 11 days ago - Bicycle Therapeutics to Participate in the Jefferies London Healthcare Conference - Business Wire
- 16 days ago - Bicycle Therapeutics: Looking Again At An Intriguing Developmental Concern - Seeking Alpha
- 22 days ago - Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 23 days ago - Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results - Business Wire
- 4 weeks ago - Bicycle Therapeutics Announces First Human Imaging Data from European Association of Nuclear Medicine 2024 Congress and Outlines Strategy for Leadership in Next-Generation Radiopharmaceuticals - Business Wire
- 5 weeks ago - Bicycle Therapeutics to Present Radiopharmaceuticals Data at European Association of Nuclear Medicine 2024 Congress - Business Wire
- 2 months ago - Bicycle Therapeutics Presents Updated Clinical Results Across Oncology Pipeline at ESMO Congress 2024 - Business Wire
- 2 months ago - Bicycle Therapeutics' Lead Cancer Candidate's Has High-Opportunity, Analyst Initiates With Bullish Tone - Benzinga